In March 2017, Michael Gilmore, PhD, Director of the Harvard Infectious Disease Institute, chaired a blue ribbon panel that reviewed the most promising applications for the Antimicrobial Resistance Diagnostic Challenge--a $20 million federal prize competition to develop innovative, rapid point-of-care laboratory diagnostic tests to combat the development, and spread, of drug resistant bacteria.
BOSTON, MASS. – Scientists from Massachusetts Eye and Ear/Harvard Medical School Department of Ophthalmology have used the power of new genomic technology to discover that microbes that commonly infect the eye have special, previously unknown properties. These properties are predicted to allow the bacterium ― Streptococcus pneumonia ― to specifically stick to the surface of the eye, grow, and cause damage and inflammation. Researchers are now using this information to develop new ways to treat Read more about Scientists Discover New Properties of Microbes That Cause Common Eye Infection